Article Information
History
- May 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Rahul S. Samant1,2,10,✉,
- Silvia Batista1,3,10,
- Mark Larance4,5,
- Bugra Ozer1,6,
- Christopher I. Milton1,
- Isabell Bludau7,
- Laura Biggins8,
- Simon Andrews8,
- Alexia Hervieu1,
- Harvey E. Johnston2,
- Bissan Al-Lazikhani1,9,
- Angus I. Lamond4,
- Paul A. Clarke1 and
- Paul Workman1,✉
- 1Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK
- 2Signalling Programme, The Babraham Institute, Cambridge, UK
- 3Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal
- 4Centre for Gene Regulation & Expression, University of Dundee, Dundee, UK
- 5Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Campersdown, NSW, Australia
- 6Healx Ltd, Cambridge, UK
- 7Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany
- 8Bioinformatics Group, The Babraham Institute, Cambridge, UK
- 9Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- ↵✉Correspondence: rahul.samant{at}babraham.ac.uk; paul.workman{at}icr.ac.uk
↵10 These authors contributed equally to this work.